Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.
about
Plant Viruses as Nanoparticle-Based Vaccines and AdjuvantsChimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumorsRabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a reviewAn enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.P2X7 receptor activation impairs exogenous MHC class I oligopeptides presentation in antigen presenting cells.An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cells.Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs.Mannosylation of virus-like particles enhances internalization by antigen presenting cellsChimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responsesLung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.A Comparison Study of iTEP Nanoparticle-Based CTL Vaccine Carriers Revealed a Surprise Relationship between the Stability and Efficiency of the Carriers.Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12.Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.Into the intracellular logistics of cross-presentation.Advances and challenges in the development and production of effective plant-based influenza vaccines.Antigen delivery by virus-like particles for immunotherapeutic vaccination.Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer.HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.Cell-permeable capsids as universal antigen carrier for the induction of an antigen-specific CD8+ T-cell response.Meeting report VLPNPV: Session 3: Immune responses.Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.Nucleolin mediates the internalization of rabbit hemorrhagic disease virus through clathrin-dependent endocytosis
P2860
Q26782569-6220F46E-824D-4765-91B8-890257FD18B1Q28484683-257AD06D-C575-4377-B56A-575B54CFA202Q28730482-6D4D7A8F-A5C2-4ED7-9B23-0034CC8E18B5Q31121276-94D7B6D9-02C2-4E67-A876-A61C6363D5D7Q33887642-2F03D4A0-360F-482D-B0E5-04DF6C2E8D72Q34935396-44376E13-19A6-44E4-9847-E39C8DD60D9CQ35137191-9F60B2EA-FB16-4F63-BEFE-322EAC4FCF09Q35140889-1D0720EF-F3C0-476F-B78C-718C18F2C5F5Q35224806-E6BA19D3-1AD7-46E8-BC75-C1BE50C15617Q35232804-3165DDFA-81A6-44A8-A9AC-40AEB068FF21Q35653886-40997799-A2E5-4C37-AA06-6B1F79BE5D5DQ35883016-9DDA6C6F-E36B-4901-AFEC-BEDD0A1E1A0FQ35913925-ABBB96B2-D057-4127-9C2C-4E89E7275A41Q36723754-F6364245-AF25-40DA-B3E1-07017F42104CQ36821184-D8448BDA-12B3-43DE-A36B-7D989D2C3657Q37195802-609E3E8A-6557-4C91-8BF4-F211F2620332Q38008356-350DE8AD-DACD-4F57-8B65-C46EDA45F549Q38285425-53A6D0AA-2E86-49AD-88E9-7CF492BCC1AFQ38285854-4C837C8B-7351-48D5-9226-174E722F4332Q38618258-F734520E-2C80-4280-98DD-D028CBE733C9Q38621219-7AC04935-FD89-49A7-A1DF-CCDAF7259A72Q39201713-2BA46A46-E15E-40D9-B095-A1BD22EECE43Q40066002-58206A96-C8A7-48B1-9513-68901735B73BQ42346865-AF933801-2B67-45AE-ADE1-731918E61E74Q55397911-1A062315-7925-438B-ACD5-B3FDFF9C70FDQ58590736-AE1EB8AE-CCCF-42CA-9001-624B2327B31D
P2860
Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cross-presentation of epitopes ...... I receptor recycling pathway.
@en
Cross-presentation of epitopes ...... I receptor recycling pathway.
@nl
type
label
Cross-presentation of epitopes ...... I receptor recycling pathway.
@en
Cross-presentation of epitopes ...... I receptor recycling pathway.
@nl
prefLabel
Cross-presentation of epitopes ...... I receptor recycling pathway.
@en
Cross-presentation of epitopes ...... I receptor recycling pathway.
@nl
P2093
P2860
P356
P1476
Cross-presentation of epitopes ...... C I receptor recycling pathway
@en
P2093
Margaret A Baird
Sarah L Young
Stephanie J Win
P2860
P304
P356
10.1038/ICB.2010.161
P577
2011-01-11T00:00:00Z